184 related articles for article (PubMed ID: 3966266)
1. Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.
Weksler BB; Kent JL; Rudolph D; Scherer PB; Levy DE
Stroke; 1985; 16(1):5-9. PubMed ID: 3966266
[TBL] [Abstract][Full Text] [Related]
2. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
[TBL] [Abstract][Full Text] [Related]
3. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man.
Böger RH; Bode-Böger SM; Gutzki FM; Tsikas D; Weskott HP; Frölich JC
Clin Sci (Lond); 1993 May; 84(5):517-24. PubMed ID: 8504628
[TBL] [Abstract][Full Text] [Related]
4. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
Serebruany VL; Malinin AI; Sane DC
Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit.
Lee TK; Chen YC; Lien IN; Liu MC; Huang ZS
Stroke; 1988 May; 19(5):566-70. PubMed ID: 3363589
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin.
Ring ME; Corrigan JJ; Fenster PE
Thromb Res; 1986 Nov; 44(3):391-400. PubMed ID: 3798404
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
8. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Lorenz R; Siess W; Weber PC
Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
[TBL] [Abstract][Full Text] [Related]
9. Effect of low dose acetylsalicylic acid upon plasma thromboxane B2 levels and platelet aggregation in ischemic stroke patients.
Lee TK; Chen YC; Kuo TL; Lien IN; Liu MC; Huang ZS
Clin Chim Acta; 1989 Oct; 184(3):323-8. PubMed ID: 2612002
[No Abstract] [Full Text] [Related]
10. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
[TBL] [Abstract][Full Text] [Related]
12. Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis.
Karwande SV; Weksler BB; Gay WA; Subramanian VA
Ann Thorac Surg; 1987 Mar; 43(3):318-22. PubMed ID: 3548616
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease.
Dougherty JH; Levy DE; Weksler BB
Lancet; 1977 Apr; 1(8016):821-4. PubMed ID: 67334
[TBL] [Abstract][Full Text] [Related]
15. Failure of aspirin to impair bovine platelet function.
Gentry PA; Tremblay RR; Ross ML
Am J Vet Res; 1989 Jun; 50(6):919-22. PubMed ID: 2764343
[TBL] [Abstract][Full Text] [Related]
16. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
[TBL] [Abstract][Full Text] [Related]
17. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
Clarke RJ; Mayo G; Price P; FitzGerald GA
N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia.
Uchiyama S; Sone R; Nagayama T; Shibagaki Y; Kobayashi I; Maruyama S; Kusakabe K
Stroke; 1989 Dec; 20(12):1643-7. PubMed ID: 2531943
[TBL] [Abstract][Full Text] [Related]
19. Dose- and time-dependent antiplatelet effects of aspirin.
Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
[TBL] [Abstract][Full Text] [Related]
20. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
